UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ABBV — AbbVie Inc.
CIK 861177
NEW YORK, NY
Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,590,323,267
+$510,315,584 QoQ
Shares Held
14,267,697
+0.7% QoQ
Ownership
0.807%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#18
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. ABBV ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
|
36,157,306 | $870,667,923 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,590,323,267 | 14,267,697 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,080,007,683 | 14,161,606 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,953,075,815 | 12,924,311 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,913,032,751 | 12,581,121 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,710,534,048 | 14,602,597 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,675,958,846 | 12,771,854 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,142,832,050 | 12,058,706 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,009,541,859 | 10,175,926 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,645,386,723 | 9,592,973 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,594,278,392 | 8,754,961 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,370,552,504 | 8,843,986 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,402,095,170 | 9,406,247 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,345,059,298 | 9,983,369 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,591,049,512 | 9,983,369 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,740,488,462 | 10,769,683 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,453,585,286 | 10,830,678 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,686,503,875 | 11,011,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,632,981,846 | 10,073,295 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,508,026,430 | 11,137,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,319,675,749 | 12,233,946 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,246,612,328 | 11,067,226 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,244,136,507 | 11,496,364 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,225,638,592 | 11,438,531 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $803,651,995 | 9,175,157 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $858,987,812 | 8,749,112 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $463,462,164 | 6,082,979 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||